The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients
Open Access
- 1 March 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Annals of Hematology
- Vol. 101 (2), 443-445
- https://doi.org/10.1007/s00277-021-04472-5
Abstract
No abstract availableFunding Information
- Wellcome Trust (WT098051)
- Cancer Research UK (C22324/A23015)
This publication has 11 references indexed in Scilit:
- Prediction of acute myeloid leukaemia risk in healthy individualsNature, 2018
- Erratum: Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaLeukemia, 2016
- Genomic Classification and Prognosis in Acute Myeloid LeukemiaNew England Journal of Medicine, 2016
- Age-Related Clonal Hematopoiesis Associated with Adverse OutcomesNew England Journal of Medicine, 2014
- Age-related mutations associated with clonal hematopoietic expansion and malignanciesNature Medicine, 2014
- PML–RARα initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitorsLeukemia, 2009
- High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARα expressionBlood, 2003
- Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences.1997
- Altered Myeloid Development and Acute Leukemia in Transgenic Mice Expressing PML-RARα Under Control of Cathepsin G Regulatory SequencesBlood, 1997
- The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RARCell, 1991